Clinical Trial Update: Axitinib + Ipilimumab in Advanced Melanoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating axitinib plus ipilimumab in advanced melanoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• INLYTA (AXITINIB)
• Yervoy (ipilimumab)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Melanoma | Phase 2 | Status: RECRUITING